Beta-hCG (β-hCG)

The Beta-hCG (β-hCG) Test at Pamel Laboratories measures the level of human chorionic gonadotropin (hCG) in the blood, specifically the beta subunit, which provides a highly accurate detection of pregnancy and is also a useful tumor marker in certain cancers.

This test is commonly used to confirm pregnancy, monitor its progression, and to help diagnose and track gestational trophoblastic diseases, testicular cancer, and ovarian tumors.

What the Test Measures:

• The beta subunit of human chorionic gonadotropin (β-hCG) in the blood

• Can detect very early pregnancy

• Used in cancer diagnosis and monitoring

Purpose of the Test:

• Confirm early pregnancy (even before a missed period)

• Monitor:

  • Normal pregnancy progression

  • Ectopic pregnancy or miscarriage risk

• Diagnose or monitor:

  • Gestational trophoblastic diseases (e.g., molar pregnancy, choriocarcinoma)

  • Testicular cancer in males

  • Ovarian germ cell tumors in females

Sample Type: Blood sample (serum)
Fasting Required: No
Turnaround Time: Same day or within 24 hours

Interpretation Guide:

• Elevated β-hCG in females: Confirms pregnancy or may suggest a gestational tumor

• Elevated β-hCG in males: May indicate testicular cancer

• Serial measurements are often used to monitor pregnancy viability or tumor progression/regression